Skip to content
OpenCapital
Get started

Travere Therapeutics, Inc. TVTX Lease Payments

Lease Payments at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
——

Other financials

Income statement

See full
Revenue$127.2M+55.6%
Gross profit$125.2M+62.5%
Operating income-$36.9M+13.5%
Net income-$37.1M+10.0%
EPS (diluted)-$0.40+14.9%

Balance sheet

See full
Cash & equivalents$78.4M+26.6%
Total debt$15.6M-82.6%
Total equity$98.7M+201%
Total assets$555.2M+1.2%

Cash flow

See full
Operating cash flow-$40.4M+4.3%
CapEx$140.0K—
Free cash flow-$42.5M+28.1%

Valuation

See full
Market cap$5.13B+72.3%

Profitability

See full
Gross margin98.6%+2.6pp
Operating margin-10.6%-5.0pp
Net margin-20.3%-9.5pp
FCF margin-133.9%-34.4pp

Returns & leverage

See full
Return on equity-706%-1,302pp
Debt / equity0.2×-2.6×
Current ratio3.1×+1.1×

Where this comes from

Reported directly by Travere Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeasePayments.

The official record: Travere Therapeutics, Inc.’s 10-K, filed February 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about Travere Therapeutics, Inc.'s lease payments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Travere Therapeutics, Inc.'s lease payments?
Travere Therapeutics, Inc. (TVTX) reported lease payments of $1.64M in Q4 2025.
How has Travere Therapeutics, Inc.'s lease payments changed year-over-year?
Travere Therapeutics, Inc.'s lease payments increased by 2.9% year-over-year, from $1.6M to $1.64M.
What is the long-term trend for Travere Therapeutics, Inc.'s lease payments?
Over 4 years (2021 to 2025), Travere Therapeutics, Inc.'s lease payments has grown at a 31.4% compound annual growth rate (CAGR), from $2.21M to $6.58M.
What does lease payments mean?
Represents the actual cash outflows associated with the periodic rental payments for operating leases. This metric is essential for understanding the company's fixed cash obligations and operational overhead requirements.